LSBio
Products
  • Antibodies
  • All Antibodies
  • Primary Antibodies
  • Secondary Antibodies
  • IHC-plus Antibodies
  • Isotype Control Antibodies
  • ELISA Kits
  • All Kits
  • Traditional ELISA Kits
  • Cell-Based ELISA Kits
  • DNA-Binding ELISA Kits
  • Phospho-Specific ELISA Kits
  • ELISA Development Kits
  • Chemiluminescent CLIA Kits
  • Proteins
  • All Proteins
  • Recombinant Proteins
  • Native Proteins
  • Over-expression Lysates
  • Cell and Tissue Lysates
  • Bio-active Proteins
  • Animal-free Proteins
  • Synthetic Peptides
  • Biochemicals
  • All Biochemicals

  • Immunohistochemistry
  • Immunohistochemistry Reagents
  • Comprehensive IHC Reports
  • Custom IHC Services
  • TCR Screening Services
  • IHC-plus Antibodies
Services
  • Immunohistochemistry Services

  • Work with LifeSpan to design a custom immunohistochemistry to address your specific biological question. Outsource the entire localization process without having to worry about finding and characterizing target specific antibodies, sourcing and validating difficult-to-find tissues, and having the ability to interpret the resulting immunostaining in relation to complex human pathologies.

  • TCR Screening Services

  • Test your therapeutic antibodies in immunohistochemistry against a broad panel of normal frozen human tissue types in order to determine potential unintended binding. Our non-GLP TCR services are designed on the FDA recommendation outlined in their "Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use".
Have a question? CustomerSupport@LSBio.com
Research Areas
  • Cancer Research Resources and Products:
  • Breast Cancer
  • Colorectal Cancer
Resources
  • Purchasing
  • Product Ordering Terms and Conditions
  • Holiday Schedule
  • About the LSBio Guarantee
  • About Reviews
  • Reference Material
  • About LSBio (LifeSpan BioSciences Inc.)
  • About Our 2-million Specimen Tissue Bank
  • About Our IHC Validation Process
  • About Our IHC-plus™ Immunohistochemistry Protocol
  • Protocols
  • Secure Logins
  • Login to Our Secure ShareFile Site
  • Login to Our IHC Database
Distributors
Contact Us

LSBio
2401 Fourth Avenue Suite 900
Seattle WA 98121

Phone: 866-819-4732 (Toll Free North America)
206-374-1102 (International)

Fax: 866-206-6909 (Toll Free North America)
206-577-4565 (International)
How to Buy - Details about how to buy our products.

Orders@LSBio.com - To submit a new order.

Customer.Support@LSBio.com - To submit questions about existing orders, pricing, availability, bulk quotes, proforma invoice requests, or other billing issues.

Technical.Support@LSBio.com - To request technical information requests about an LSBio product or its application.

Sales@LSBio.com - To request information about fee-for-service contract IHC studies, IHC reports, distribution agreements, or general business development.

Worldwide Distributors List - To find your local distributor if you're not within the United States.
Login ▾
Wish List
View Cart

Unfortunately, the antibody (ID:155833) is no longer available.

Below is a list of antibodies to the same protein target. You may also try your search again using the search box at the top of the page. Please contact us if you have any questions.



CA9 / Carbonic Anhydrase IX

carbonic anhydrase IX

Carbonic anhydrases (CAs) are a large family of zinc metalloenzymes that catalyze the reversible hydration of carbon dioxide. They participate in a variety of biological processes, including respiration, calcification, acid-base balance, bone resorption, and the formation of aqueous humor, cerebrospinal fluid, saliva, and gastric acid. They show extensive diversity in tissue distribution and in their subcellular localization. CA IX is a transmembrane protein and is one of only two tumor-associated carbonic anhydrase isoenzymes known. It is expressed in all clear-cell renal cell carcinoma, but is not detected in normal kidney or most other normal tissues. It may be involved in cell proliferation and transformation. This gene was mapped to 17q21.2 by fluorescence in situ hybridization, however, radiation hybrid mapping localized it to 9p13-p12.

Gene Name: carbonic anhydrase IX
Synonyms: CA9, CAIX, Carbonate dehydratase IX, Carbonic anhydrase IX, CA-IX, Carbonic dehydratase, G250, MN, Membrane antigen MN, p54/58N, RCC-associated antigen G250, RCC-associated protein G250, Carbonic anhydrase 9, PMW1
Target Sequences: NM_001216 NP_001207.2 Q16790

Publications (47)

1
[Recent evaluation of a Candida hemagglutination test]. Mller J. Mycoses. 1991 63-7. (IHC-P; Human) [PubMed:1818266]
2
Carbonic anhydrase IX expression predicts outcome of interleukin 2 therapy for renal cancer. Atkins M, Regan M, McDermott D, Mier J, Stanbridge E, Youmans A, Febbo P, Upton M, Lechpammer M, Signoretti S. Clinical cancer research : an official journal of the American Association for Cancer Research. 2005 11:3714-21. (IHC; Human) [PubMed:15897568]
3
Angiogenesis and hypoxia in lymph node metastases is predicted by the angiogenesis and hypoxia in the primary tumour in patients with breast cancer. Van den Eynden GG, Van der Auwera I, Van Laere SJ, Colpaert CG, Turley H, Harris AL, van Dam P, Dirix LY, Vermeulen PB, Van Marck EA. British journal of cancer. 2005 93:1128-36. (IHC-P; Human) [PubMed:16251878] [PMC:PMC2361504]
4
Expression of the hypoxia marker carbonic anhydrase 9 is associated with anaplastic phenotypes in meningiomas. Yoo H, Baia GS, Smith JS, McDermott MW, Bollen AW, Vandenberg SR, Lamborn KR, Lal A. Clinical cancer research : an official journal of the American Association for Cancer Research. 2007 13:68-75. (IHC-P; Human) [PubMed:17200340]
5
Hypoxia can be detected in irradiated normal human tissue: a study using the hypoxic marker pimonidazole hydrochloride. Westbury CB, Pearson A, Nerurkar A, Reis-Filho JS, Steele D, Peckitt C, Sharp G, Yarnold JR. The British journal of radiology. 2007 80:934-8. (IHC-P; Human) [PubMed:17908818]
6
Is the downregulation of EphB2 receptor expression during colorectal tumorigenesis due to hypoxia?. Kaidi A, Moorghen M, Williams AC, Paraskeva C. Gut. 2007 56:1637-8. (IHC-P; Human) [PubMed:17938437] [PMC:PMC2095662]
7
Brachytherapy for oral tongue cancer: an analysis of treatment results with various biological markers. Sakata K, Someya M, Nagakura H, Nakata K, Oouchi A, Takagi M, Hareyama M. Japanese journal of clinical oncology. 2008 38:402-7. (IHC-P; Human) [PubMed:18573850]
8
gammaH2AX expression in tumors exposed to cisplatin and fractionated irradiation. Bauelos CA, Banth JP, Kim JY, Aquino-Parsons C, Olive PL. Clinical cancer research : an official journal of the American Association for Cancer Research. 2009 15:3344-53. (IHC-P; Human) [PubMed:19401347]
9
Hypoxia-mediated up-regulation of Pim-1 contributes to solid tumor formation. Chen J, Kobayashi M, Darmanin S, Qiao Y, Gully C, Zhao R, Kondo S, Wang H, Wang H, Yeung SC, Lee MH. The American journal of pathology. 2009 175:400-11. (IHC-P; Mouse) [PubMed:19528349] [PMC:PMC2708825]
10
Inhibition of prolyl hydroxylase domain proteins promotes therapeutic revascularization. Loinard C, Ginouvs A, Vilar J, Cochain C, Zouggari Y, Recalde A, Duriez M, Lvy BI, Pouyssgur J, Berra E, Silvestre JS. Circulation. 2009 120:50-9. (WB; Mouse, Human) [PubMed:19546390]
11
Mediators of glioblastoma resistance and invasion during antivascular endothelial growth factor therapy. Lucio-Eterovic AK, Piao Y, de Groot JF. Clinical cancer research : an official journal of the American Association for Cancer Research. 2009 15:4589-99. (IHC-P; Human) [PubMed:19567589]
12
Identification of a novel small molecule HIF-1alpha translation inhibitor. Narita T, Yin S, Gelin CF, Moreno CS, Yepes M, Nicolaou KC, Van Meir EG. Clinical cancer research : an official journal of the American Association for Cancer Research. 2009 15:6128-36. (WB; Human) [PubMed:19789328] [PMC:PMC2770235]
13
Hypoxia stimulates CXCR4 signalling in ileal carcinoids. Arvidsson Y, Bergstrm A, Arvidsson L, Kristiansson E, Ahlman H, Nilsson O. Endocrine-related cancer. 2010 17:303-16. (IHC; Human) [PubMed:20071457]
14
Expression of a hypoxia-associated protein, carbonic anhydrase-9, correlates with malignant phenotypes of gastric carcinoma. Kato Y, Yashiro M, Noda S, Kashiwagi S, Matsuoka J, Fuyuhiro Y, Doi Y, Hirakawa K. Digestion. 2010 82:246-51. (IHC; Human) [PubMed:20588040]
15
Distinguishing clear cell renal cell carcinoma, retroperitoneal paraganglioma, and adrenal cortical lesions on limited biopsy material: utility of immunohistochemical markers. Lapinski JE, Chen L, Zhou M. Applied immunohistochemistry & molecular morphology : AIMM / official publication of the Society for Applied Immunohistochemistry. 2010 18:414-21. (IHC; Human) [PubMed:20861762]
16
Role of hypoxia and EGF on expression, activity, localization and phosphorylation of carbonic anhydrase IX in MDA-MB-231 breast cancer cells. Li Y, Wang H, Tu C, Shiverick KT, Silverman DN, Frost SC. Biochimica et biophysica acta. 2011 1813:159-67. (WB; Human) [PubMed:20920536] [PMC:PMC3014402]
17
Angiogenesis and host immune response contribute to the aggressive character of non-melanoma skin cancers in renal transplant recipients. Mackenzie KA, Miller AP, Hock BD, Gardner J, Simcock JW, Roake JA, Dachs GU, Robinson BA, Currie MJ. Histopathology. 2011 58:875-85. (IHC; Human) [PubMed:21585427]
18
Role of immunohistochemistry in the evaluation of needle core biopsies in adult renal cortical tumors: an ex vivo study. Al-Ahmadie HA, Alden D, Fine SW, Gopalan A, Touijer KA, Russo P, Reuter VE, Tickoo SK. The American journal of surgical pathology. 2011 35:949-61. (IHC; Human) [PubMed:21677535]
19
Hypoxia-inducible factor-1 mRNA: a new target for destabilization by tristetraprolin in endothelial cells. Chamboredon S, Ciais D, Desroches-Castan A, Savi P, Bono F, Feige JJ, Cherradi N. Molecular biology of the cell. 2011 22:3366-78. (WB; Human) [PubMed:21775632] [PMC:PMC3172262]
20
Hyperpolarized 13C MR spectroscopic imaging can be used to monitor Everolimus treatment in vivo in an orthotopic rodent model of glioblastoma. Chaumeil MM, Ozawa T, Park I, Scott K, James CD, Nelson SJ, Ronen SM. NeuroImage. 2012 59:193-201. (IHC-P; Rat) [PubMed:21807103] [PMC:PMC3196046]
21
Investigation on tumor hypoxia in resectable primary prostate cancer as demonstrated by 18F-FAZA PET/CT utilizing multimodality fusion techniques. Garcia-Parra R, Wood D, Shah RB, Siddiqui J, Hussain H, Park H, Desmond T, Meyer C, Piert M. European journal of nuclear medicine and molecular imaging. 2011 38:1816-23. (IHC-P; Human) [PubMed:21833840] [PMC:PMC3259612]
22
Pronounced hypoxia in models of murine and human leukemia: high efficacy of hypoxia-activated prodrug PR-104. Benito J, Shi Y, Szymanska B, Carol H, Boehm I, Lu H, Konoplev S, Fang W, Zweidler-McKay PA, Campana D, Borthakur G, Bueso-Ramos C, Shpall E, Thomas DA, Jordan CT, Kantarjian H, Wilson WR, Lock R, Andreeff M, Konopleva M. PloS one. 2011 6:e23108. [PubMed:21853076] [PMC:PMC3154919]
23
The chromatin remodeler ISWI regulates the cellular response to hypoxia: role of FIH. Melvin A, Mudie S, Rocha S. Molecular biology of the cell. 2011 22:4171-81. (Human) [PubMed:21900490] [PMC:PMC3204077]
24
Inclusive estimation of complex antigen presentation functions of monocyte-derived dendritic cells differentiated under normoxia and hypoxia conditions. Ogino T, Onishi H, Suzuki H, Morisaki T, Tanaka M, Katano M. Cancer immunology, immunotherapy : CII. 2012 61:409-24. [PubMed:21932134]
25
Diflavin oxidoreductases activate the bioreductive prodrug PR-104A under hypoxia. Guise CP, Abbattista MR, Tipparaju SR, Lambie NK, Su J, Li D, Wilson WR, Dachs GU, Patterson AV. Molecular pharmacology. 2012 81:31-40. [PubMed:21984255]
26
Lowered expression of galectin-2 is associated with lymph node metastasis in gastric cancer. Jung JH, Kim HJ, Yeom J, Yoo C, Shin J, Yoo J, Kang CS, Lee C. Journal of gastroenterology. 2012 47:37-48. (WB; Human) [PubMed:22015694]
27
The expression of the hypoxia markers CA9 and CXCR4 is correlated with survival in patients with neuroendocrine tumours of the ileum. Deschamps L, Bacha D, Rebours V, Mebarki M, Bretagnol F, Panis Y, Bedossa P, Ruszniewski P, Couvelard A. Neuroendocrinology. 2012 95:214-22. (IHC; Human) [PubMed:22133596]
28
Increased activation of the hypoxia-inducible factor pathway in varicose veins. Lim CS, Kiriakidis S, Paleolog EM, Davies AH. Journal of vascular surgery. 2012 55:1427-39. (WB; Human) [PubMed:22277691]
29
Hypoxia promotes ligand-independent EGF receptor signaling via hypoxia-inducible factor-mediated upregulation of caveolin-1. Wang Y, Roche O, Xu C, Moriyama EH, Heir P, Chung J, Roos FC, Chen Y, Finak G, Milosevic M, Wilson BC, Teh BT, Park M, Irwin MS, Ohh M. Proceedings of the National Academy of Sciences of the United States of America. 2012 109:4892-7. (WB, GS; Human) [PubMed:22411794] [PMC:PMC3323978]
30
Morphophenotypic characteristics of intralymphatic cancer and stromal cells susceptible to lymphogenic metastasis. Matsumura Y, Ishii G, Aokage K, Kuwata T, Hishida T, Yoshida J, Nishimura M, Nagai K, Ochiai A. Cancer science. 2012 103:1342-7. (IHC; Human) [PubMed:22429811]
31
Molecular profiling of pancreatic neuroendocrine tumors in sporadic and Von Hippel-Lindau patients. Speisky D, Duces A, Biche I, Rebours V, Hammel P, Sauvanet A, Richard S, Bedossa P, Vidaud M, Murat A, Niccoli P, Scoazec JY, Ruszniewski P, Couvelard A. Clinical cancer research : an official journal of the American Association for Cancer Research. 2012 18:2838-49. (IHC; Human) [PubMed:22461457]
32
Hedgehog inhibitor decreases chemosensitivity to 5-fluorouracil and gemcitabine under hypoxic conditions in pancreatic cancer. Onishi H, Morifuji Y, Kai M, Suyama K, Iwasaki H, Katano M. Cancer science. 2012 103:1272-9. (ICC, IHC; Mouse) [PubMed:22486854]
33
The prognostic value of expression of HIF1, EGFR and VEGF-A, in localized prostate cancer for intermediate- and high-risk patients treated with radiation therapy with or without androgen deprivation therapy. Weber DC, Tille JC, Combescure C, Egger JF, Laouiti M, Hammad K, Granger P, Rubbia-Brandt L, Miralbell R. Radiation oncology (London, England). 2012 7:66. (IHC; Human) [PubMed:22546016] [PMC:PMC3432017]
34
SIRT3 protects from hypoxia and staurosporine-mediated cell death by maintaining mitochondrial membrane potential and intracellular pH. Pellegrini L, Pucci B, Villanova L, Marino ML, Marfe G, Sansone L, Vernucci E, Bellizzi D, Reali V, Fini M, Russo MA, Tafani M. Cell death and differentiation. 2012 19:1815-25. (WB; Human) [PubMed:22595756] [PMC:PMC3469066]
35
Predictive factors for response to treatment in patients with advanced renal cell carcinoma. Muriel Lpez C, Esteban E, Astudillo A, Pardo P, Berros JP, Izquierdo M, Crespo G, Fonseca PJ, Sanmamed M, Martnez-Camblor P. Investigational new drugs. 2012 30:2443-9. (IHC; Human) [PubMed:22644070]
36
Hypoxia enhances the interaction between pancreatic stellate cells and cancer cells via increased secretion of connective tissue growth factor. Engler JR, Robinson AE, Smirnov I, Hodgson JG, Berger MS, Gupta N, James CD, Molinaro A, Phillips JJ. The Journal of surgical research. 2012 (IHC; Human) [PubMed:22795353]
37
Asic3 is a neuronal mechanosensor for pressure-induced vasodilation that protects against pressure ulcers. Engler JR, Robinson AE, Smirnov I, Hodgson JG, Berger MS, Gupta N, James CD, Molinaro A, Phillips JJ. Nature medicine. 2012 (IHC; Mouse) [PubMed:22842475]
38
Arylsulfonamide KCN1 inhibits in vivo glioma growth and interferes with HIF signaling by disrupting HIF-1 interaction with cofactors p300/CBP. Yin S, Kaluz S, Devi NS, Jabbar AA, de Noronha RG, Mun J, Zhang Z, Boreddy PR, Wang W, Wang Z, Abbruscato T, Chen Z, Olson JJ, Zhang R, Goodman MM, Nicolaou KC, Van Meir EG. Clinical cancer research : an official journal of the American Association for Cancer Research. 2012 18:6623-33. (WB; Human) [PubMed:22923450] [PMC:PMC3518680]
39
Increased microglia/macrophage gene expression in a subset of adult and pediatric astrocytomas. Engler JR, Robinson AE, Smirnov I, Hodgson JG, Berger MS, Gupta N, James CD, Molinaro A, Phillips JJ. PloS one. 2012 7:e43339. (IHC; Human) [PubMed:22937035] [PMC:PMC3425586]
40
EG-VEGF controls placental growth and survival in normal and pathological pregnancies: case of fetal growth restriction (FGR). Brouillet S, Murthi P, Hoffmann P, Salomon A, Sergent F, De Mazancourt P, Dakouane-Giudicelli M, Dieudonn MN, Rozenberg P, Vaiman D, Barbaux S, Benharouga M, Feige JJ, Alfaidy N. Cellular and molecular life sciences : CMLS. 2013 70:511-25. (IHC; Human) [PubMed:22941044]
41
Prognostic factors in patients with advanced renal cell carcinoma. Muriel Lpez C, Esteban E, Berros JP, Pardo P, Astudillo A, Izquierdo M, Crespo G, Sanmamed M, Fonseca PJ, Martnez-Camblor P. Clinical genitourinary cancer. 2012 10:262-70. (IHC; Human) [PubMed:22959659]
42
Glioblastoma resistance to anti-VEGF therapy is associated with myeloid cell infiltration, stem cell accumulation, and a mesenchymal phenotype. Piao Y, Liang J, Holmes L, Zurita AJ, Henry V, Heymach JV, de Groot JF. Neuro-oncology. 2012 14:1379-92. (IHC; Mouse, Human) [PubMed:22965162] [PMC:PMC3480262]
43
Immunohistochemical analysis of cancer stem cell markers in invasive breast carcinoma and associated ductal carcinoma in situ: relationships with markers of tumor hypoxia and microvascularity. Currie MJ, Beardsley BE, Harris GC, Gunningham SP, Dachs GU, Dijkstra B, Morrin HR, Wells JE, Robinson BA. Human pathology. 2013 44:402-11. (IHC; Human) [PubMed:23036368]
44
Function of carbonic anhydrase IX in glioblastoma multiforme. Proescholdt MA, Merrill MJ, Stoerr EM, Lohmeier A, Pohl F, Brawanski A. Neuro-oncology. 2012 14:1357-66. (IHC, WB; Human) [PubMed:23074198] [PMC:PMC3480266]
45
Steep increase in myonuclear domain size during infancy. Delhaas T, Van der Meer SF, Schaart G, Degens H, Drost MR. Anatomical record (Hoboken, N.J. : 2007). 2013 296:192-7. (ICC, IHC; Human) [PubMed:23213045]
46
Immunohistochemical markers of the hypoxic response can identify malignancy in phaeochromocytomas and paragangliomas and optimize the detection of tumours with VHL germline mutations. Pinato DJ, Ramachandran R, Toussi ST, Vergine M, Ngo N, Sharma R, Lloyd T, Meeran K, Palazzo F, Martin N, Khoo B, Dina R, Tan TM. British journal of cancer. 2013 108:429-37. (IHC; Human) [PubMed:23257898] [PMC:PMC3566818]
47
Radiosensitization of normoxic and hypoxic h1339 lung tumor cells by heat shock protein 90 inhibition is independent of hypoxia inducible factor-1a. Schilling D, Bayer C, Li W, Molls M, Vaupel P, Multhoff G. PloS one. 2012 7:e31110. (WB; Human) [Full Text Article] [PubMed:22347438] [PMC:PMC3274537]
more

Filtered By: None
Target
ca9-carbonic-anhydrase-ix (82)
Reactivity
Human (73)
Mouse (9)
Rat (3)
Dog (7)
Horse (15)
Plant (2)
Application
IHC (46)
IHC-P (36)
WB (63)
Flo (27)
ELISA (30)
IF (24)
IP (9)
Peptide-ELISA (1)
Host
rabbit (51)
mouse (31)
Isotype
IgG (31)
IgG1 (5)
IgG2a (4)
IgG2b (1)
IgG2b,k (18)
Clonality
monoclonal mc (32)
polyclonal pc (50)
Clone
10F7A8 (1)
12F10 (1)
1G7 (1)
2D3 (2)
303123 (1)
66.4.C2 (3)
7C4A5 (1)
CA9/781 (3)
CBAD9-1 (3)
EPR4151(2) (1)
PN-15 (3)
SP106 (1)
SPM314 (3)
SPM487 (3)
Format
AP Conjugated (2)
APC Conjugated (3)
Azide-free (6)
Biotin Conjugated (5)
CF Conjugated (1)
DY488 Conjugated (1)
DY550 Conjugated (1)
DY650 Conjugated (1)
FITC Conjugated (4)
HRP Conjugated (2)
PE Conjugated (3)
Ready-to-Use (6)
Unconjugated (59)
Epitope
aa63-90 (8)
C-Terminus (7)
aa59-414 (4)
aa88-280 (3)
Internal (2)
aa37-186 (2)
Asp82 (1)
Extracellular Domain (1)
aa113-143 (1)
aa33-82 (1)
Publications
No (82)
Showing 1-25 out of 82 results
Anti-CA9 / Carbonic Anhydrase IX Antibody (Extracellular Domain, clone EPR4151(2)) IHC-plus™ LS-B7323
Anti-CA9 / Carbonic Anhydrase IX antibody IHC of human liver, bile duct. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval. Antibody LS-B7323 dilution 1:50.
Western blot analysis on (A) HT-29 and (B) human stomach lysates using anti-Carbonic Anhydrase 9 antibody.

Rabbit Monoclonal [clone EPR4151(2)] to Human CA9 / Carbonic Anhydrase IX
Human
IHC IHC-P WB
Unconjugated
Anti-CA9 / Carbonic Anhydrase IX Antibody (C-Terminus) IHC-plus™ LS-B273
Anti-CA9 / Carbonic Anhydrase IX antibody IHC of human liver. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval. Antibody LS-B273 concentration 5 ug/ml.  This image was taken for the unconjugated form of this product. Other forms have not been tested.
Anti-CA9 / Carbonic Anhydrase IX antibody IHC of human stomach. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval. Antibody LS-B273 concentration 0.625 ug/ml.  This image was taken for the unconjugated form of this product. Other forms have not been tested.

Rabbit Polyclonal to Human CA9 / Carbonic Anhydrase IX
Mouse, Dog, Rat, Plant, Human
IHC IHC-P
Unconjugated
Anti-CA9 / Carbonic Anhydrase IX Antibody (C-Terminus, Biotin) LS-C83728
Renal carcinoma tissue stained with polyclonal carbonic anhydrase IX.  This image was taken for the unconjugated form of this product. Other forms have not been tested.
Anti-CA9 / Carbonic Anhydrase IX antibody IHC of human liver. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval. Antibody LS-B273 concentration 5 ug/ml.  This image was taken for the unconjugated form of this product. Other forms have not been tested.

Rabbit Polyclonal to Human CA9 / Carbonic Anhydrase IX
Mouse, Dog, Rat, Plant, Human
IF IHC IHC-P WB
Biotin Conjugated
Anti-CA9 / Carbonic Anhydrase IX Antibody (clone 303123, PE) LS-C35270

Mouse Monoclonal [clone 303123] (IgG2a) to Human CA9 / Carbonic Anhydrase IX
Human
Flo
PE Conjugated
Anti-CA9 / Carbonic Anhydrase IX Antibody (C-Terminus) LS-C137056
Western blot Image

Rabbit Polyclonal (IgG) to Human CA9 / Carbonic Anhydrase IX
Human
ELISA IHC WB
Unconjugated
Anti-CA9 / Carbonic Anhydrase IX Antibody (clone 2D3) LS-C169297
IHC of paraffin-embedded stomach tissues (left) and colon tissues (right) using CA9 mouse monoclonal antibody with DAB staining.
Western blot using CA9 mouse monoclonal antibody against HeLa (1) and A549 (2) cell lysate.

Mouse Monoclonal [clone 2D3] (IgG1) to Human CA9 / Carbonic Anhydrase IX
Human
ELISA Flo IHC IHC-P
Unconjugated
Anti-CA9 / Carbonic Anhydrase IX Antibody (aa59-414) LS-C143678

Mouse Monoclonal (IgG2a) to Human CA9 / Carbonic Anhydrase IX
Human
ELISA Flo IP
Unconjugated
Anti-CA9 / Carbonic Anhydrase IX Antibody (clone SP106) LS-C210355
Immunohistochemistry of Human Stomach stained with anti-Carbonic Anhydrase 9 (CA-9) antibody
Immunohistochemistry of Human Stomach stained with anti-Carbonic Anhydrase 9 (CA-9) antibody

Rabbit Monoclonal [clone SP106] (IgG) to Human CA9 / Carbonic Anhydrase IX
Human
Flo IHC IHC-P
Unconjugated
Anti-CA9 / Carbonic Anhydrase IX Antibody (clone 66.4.C2) LS-C357729

Mouse Monoclonal [clone 66.4.C2] (IgG2b,k) to Human CA9 / Carbonic Anhydrase IX
Horse, Human
ELISA Flo IF IHC IHC-P IP WB
Unconjugated
Anti-CA9 / Carbonic Anhydrase IX Antibody (clone 66.4.C2, Azide-free) LS-C389436

Mouse Monoclonal [clone 66.4.C2] (IgG2b,k) to Human CA9 / Carbonic Anhydrase IX
Horse, Human
ELISA Flo IF IHC IHC-P IP WB
Unconjugated, Azide-free
Anti-CA9 / Carbonic Anhydrase IX Antibody (clone 66.4.C2, Ready-to-Use) LS-C389451

Mouse Monoclonal [clone 66.4.C2] (IgG2b,k) to Human CA9 / Carbonic Anhydrase IX
Horse, Human
ELISA Flo IF IHC IHC-P IP WB
Unconjugated, Ready-to-Use
Anti-CA9 / Carbonic Anhydrase IX Antibody (clone 2D3) LS-C359288
Immunohistochemistry-Paraffin: Carbonic Anhydrase IX Antibody (2D3) - Immunohistochemical analysis of paraffin-embedded lung tissues (left) and colonic tissues (right) using Carbonic Anhydrase IX mouse mAb with DAB staining.  This image was taken for the unconjugated form of this product. Other forms have not been tested.
Western Blot: Carbonic Anhydrase IX Antibody (2D3) - Western blot analysis using Carbonic Anhydrase IX mouse mAb against HeLa (1) and A549 (2) cell lysates.  This image was taken for the unconjugated form of this product. Other forms have not been tested.

Mouse Monoclonal [clone 2D3] (IgG1) to Human CA9 / Carbonic Anhydrase IX
Human
ELISA Flo IHC IHC-P WB
Unconjugated
Anti-CA9 / Carbonic Anhydrase IX Antibody (clone PN-15) LS-C391157
Formalin-fixed, paraffin-embedded human renal cell carcinoma stained with Carbonic Anhydrase 9 antibody (PN-15).  This image was taken for the unmodified form of this product. Other forms have not been tested.

Mouse Monoclonal [clone PN-15] (IgG2b,k) to Human CA9 / Carbonic Anhydrase IX
Horse, Human
Flo IF IHC IHC-P WB
Unconjugated
Anti-CA9 / Carbonic Anhydrase IX Antibody (clone PN-15, Ready-to-Use) LS-C391150
Formalin-fixed, paraffin-embedded human renal cell carcinoma stained with Carbonic Anhydrase 9 antibody (PN-15).  This image was taken for the unmodified form of this product. Other forms have not been tested.

Mouse Monoclonal [clone PN-15] (IgG2b,k) to Human CA9 / Carbonic Anhydrase IX
Horse, Human
Flo IF IHC IHC-P WB
Unconjugated, Ready-to-Use
Anti-CA9 / Carbonic Anhydrase IX Antibody (clone PN-15, Azide-free) LS-C391154
Formalin-fixed, paraffin-embedded human renal cell carcinoma stained with Carbonic Anhydrase 9 antibody (PN-15).  This image was taken for the unmodified form of this product. Other forms have not been tested.

Mouse Monoclonal [clone PN-15] (IgG2b,k) to Human CA9 / Carbonic Anhydrase IX
Horse, Human
Flo IF IHC IHC-P WB
Unconjugated, Azide-free
Anti-CA9 / Carbonic Anhydrase IX Antibody (clone SPM314) LS-C392441
Formalin-fixed, paraffin-embedded human renal cell carcinoma stained with CA9 antibody (SPM314).  This image was taken for the unmodified form of this product. Other forms have not been tested.

Mouse Monoclonal [clone SPM314] (IgG2b,k) to Human CA9 / Carbonic Anhydrase IX
Horse, Human
Flo IF IHC IHC-P WB
Unconjugated
Anti-CA9 / Carbonic Anhydrase IX Antibody (clone SPM314, Azide-free) LS-C392440
Formalin-fixed, paraffin-embedded human renal cell carcinoma stained with CA9 antibody (SPM314).  This image was taken for the unmodified form of this product. Other forms have not been tested.

Mouse Monoclonal [clone SPM314] (IgG2b,k) to Human CA9 / Carbonic Anhydrase IX
Horse, Human
Flo IF IHC IHC-P WB
Unconjugated, Azide-free
Anti-CA9 / Carbonic Anhydrase IX Antibody (clone SPM314, Ready-to-Use) LS-C392446
Formalin-fixed, paraffin-embedded human renal cell carcinoma stained with CA9 antibody (SPM314).  This image was taken for the unmodified form of this product. Other forms have not been tested.

Mouse Monoclonal [clone SPM314] (IgG2b,k) to Human CA9 / Carbonic Anhydrase IX
Horse, Human
Flo IF IHC IHC-P WB
Unconjugated, Ready-to-Use
Anti-CA9 / Carbonic Anhydrase IX Antibody (clone SPM487) LS-C392443
Formalin-fixed, paraffin-embedded human renal cell carcinoma stained with Carbonic Anhydrase IX antibody (SPM487).  This image was taken for the unmodified form of this product. Other forms have not been tested.

Mouse Monoclonal [clone SPM487] (IgG2b,k) to Human CA9 / Carbonic Anhydrase IX
Horse, Human
Flo IF IHC IHC-P WB
Unconjugated
Anti-CA9 / Carbonic Anhydrase IX Antibody (clone SPM487, Ready-to-Use) LS-C392445
Formalin-fixed, paraffin-embedded human renal cell carcinoma stained with Carbonic Anhydrase IX antibody (SPM487).  This image was taken for the unmodified form of this product. Other forms have not been tested.

Mouse Monoclonal [clone SPM487] (IgG2b,k) to Human CA9 / Carbonic Anhydrase IX
Horse, Human
Flo IF IHC IHC-P WB
Unconjugated, Ready-to-Use
Anti-CA9 / Carbonic Anhydrase IX Antibody (clone SPM487, Azide-free) LS-C392451
Formalin-fixed, paraffin-embedded human renal cell carcinoma stained with Carbonic Anhydrase IX antibody (SPM487).  This image was taken for the unmodified form of this product. Other forms have not been tested.

Mouse Monoclonal [clone SPM487] (IgG2b,k) to Human CA9 / Carbonic Anhydrase IX
Horse, Human
Flo IF IHC IHC-P WB
Unconjugated, Azide-free
Anti-CA9 / Carbonic Anhydrase IX Antibody (clone CA9/781) LS-C391149
Formalin-fixed, paraffin-embedded human renal cell carcinoma stained with CAIX antibody (CA9/781).  This image was taken for the unmodified form of this product. Other forms have not been tested.
Western blot analysis of HCT116 cell lysate using CAIX antibody (CA9/781). Predicted molecular weight: 50-55 kDa.  This image was taken for the unmodified form of this product. Other forms have not been tested.

Mouse Monoclonal [clone CA9/781] (IgG2b,k) to Human CA9 / Carbonic Anhydrase IX
Horse, Human
Flo IF IHC IHC-P WB
Unconjugated
Anti-CA9 / Carbonic Anhydrase IX Antibody (clone CA9/781, Azide-free) LS-C391147
Formalin-fixed, paraffin-embedded human renal cell carcinoma stained with CAIX antibody (CA9/781).  This image was taken for the unmodified form of this product. Other forms have not been tested.
Western blot analysis of HCT116 cell lysate using CAIX antibody (CA9/781). Predicted molecular weight: 50-55 kDa.  This image was taken for the unmodified form of this product. Other forms have not been tested.

Mouse Monoclonal [clone CA9/781] (IgG2b,k) to Human CA9 / Carbonic Anhydrase IX
Horse, Human
Flo IF IHC IHC-P WB
Unconjugated, Azide-free
Anti-CA9 / Carbonic Anhydrase IX Antibody (clone CA9/781, Ready-to-Use) LS-C391151
Formalin-fixed, paraffin-embedded human renal cell carcinoma stained with CAIX antibody (CA9/781).  This image was taken for the unmodified form of this product. Other forms have not been tested.
Western blot analysis of HCT116 cell lysate using CAIX antibody (CA9/781). Predicted molecular weight: 50-55 kDa.  This image was taken for the unmodified form of this product. Other forms have not been tested.

Mouse Monoclonal [clone CA9/781] (IgG2b,k) to Human CA9 / Carbonic Anhydrase IX
Horse, Human
Flo IF IHC IHC-P WB
Unconjugated, Ready-to-Use
Anti-CA9 / Carbonic Anhydrase IX Antibody (clone 1G7) LS-C114719
IHC of paraffin-embedded endometrium tissue using anti-CA9 mouse monoclonal antibody. (Dilution 1:50).
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY CA9 (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-CA9.

Mouse Monoclonal [clone 1G7] (IgG2b) to Human CA9 / Carbonic Anhydrase IX
Human
Flo IHC IHC-P WB
Unconjugated

Selected:

If you do not find the reagent or information you require, please contact customer.support@lsbio.com to inquire about additional products in development.

PLEASE NOTE

For RESEARCH USE ONLY. Not intended for human diagnostic or therapeutic purposes.

The data on this page has been compiled from LifeSpan internal sources, the National Center for Biotechnology Information (NCBI), and The Universal Protein Resource (UniProt).


Get Social With Us! Follow us on Facebook Follow us on Google+ Follow us on LinkedIn PSL Alliance Member
Copyright © 2018 LifeSpan BioSciences, Inc. All Rights Reserved Privacy Policy



Catalog Number